azathioprine has been researched along with Castleman Disease in 7 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Castleman Disease: Large benign, hyperplastic lymph nodes. The more common hyaline vascular subtype is characterized by small hyaline vascular follicles and interfollicular capillary proliferations. Plasma cells are often present and represent another subtype with the plasma cells containing IgM and IMMUNOGLOBULIN A.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A man with multicentric angiofollicular lymph node hyperplasia and a polyclonal gammopathy developed a debilitating sensory-motor peripheral neuropathy that resolved with plasma-pheresis and immunosuppressive therapy." | 2.38 | Angiofollicular lymph node hyperplasia and peripheral neuropathy. Case report and literature review. ( May, E; Scherokman, B; Vukelja, SJ, 1991) |
| "Mixed Connective Tissue Disorder with Castleman's Disease is a rare association; the patient presenting with varied and interesting manifestations." | 1.36 | Mixed connective tissue disorder and Castleman's disease. ( Boorugu, HK; Chrispal, A; Thomas, EM; Vasuki, Z, 2010) |
| "To report a case of localized orbital Castleman's disease of mixed cell type with a follow-up of 20 years." | 1.31 | Castleman's disease in the orbit. A 20-year follow-up. ( Alyahya, GA; Heegaard, S; Prause, JU, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Irrera, M | 1 |
| Bozzola, E | 1 |
| Cardoni, A | 1 |
| DeVito, R | 1 |
| Diociaiuti, A | 1 |
| El Hachem, M | 1 |
| Girardi, K | 1 |
| Marchesi, A | 1 |
| Villani, A | 1 |
| Benjamin, B | 1 |
| Zaltzman, R | 1 |
| Shpitz, B | 1 |
| Gordon, CR | 1 |
| Avital, S | 1 |
| Chrispal, A | 1 |
| Vasuki, Z | 1 |
| Thomas, EM | 1 |
| Boorugu, HK | 1 |
| Műzes, G | 1 |
| Sipos, F | 1 |
| Csomor, J | 1 |
| Sréter, L | 1 |
| Alyahya, GA | 1 |
| Prause, JU | 1 |
| Heegaard, S | 1 |
| Chan, TM | 1 |
| Cheng, IK | 1 |
| Wong, KL | 1 |
| Chan, KW | 1 |
| Scherokman, B | 1 |
| Vukelja, SJ | 1 |
| May, E | 1 |
1 review available for azathioprine and Castleman Disease
| Article | Year |
|---|---|
Angiofollicular lymph node hyperplasia and peripheral neuropathy. Case report and literature review.
Topics: Aged; Azathioprine; Castleman Disease; Humans; Immunosuppression Therapy; Male; Peripheral Nervous S | 1991 |
6 other studies available for azathioprine and Castleman Disease
| Article | Year |
|---|---|
Paraneoplastic pemphigus and Castleman's disease: a case report and a revision of the literature.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Castleman Disease; Child; Female; Humans; Pemphig | 2023 |
Presacral Mass Discovered during Pregnancy followed by Myasthenia Gravis.
Topics: Adult; Azathioprine; Castleman Disease; Cholinesterase Inhibitors; Female; Humans; Immunosuppressive | 2015 |
Mixed connective tissue disorder and Castleman's disease.
Topics: Adolescent; Azathioprine; Biopsy; Castleman Disease; Female; Glomerulonephritis, Membranoproliferati | 2010 |
Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cast | 2013 |
Castleman's disease in the orbit. A 20-year follow-up.
Topics: Adult; Azathioprine; Castleman Disease; Combined Modality Therapy; Exophthalmos; Female; Follow-Up S | 2002 |
Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's disease).
Topics: Adult; Azathioprine; Biopsy; Castleman Disease; Complement System Proteins; Cyclophosphamide; Drug T | 1993 |